ESTRO 38 - Programme Book & Exhibition Guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

SATURDAY 27 APRIL 2019

> Randomized therapeutic trial of combined pentoclo versus placebo in radiation-induced plexopathy S. Delanian (France), T. Maisonobe, T. Lenglet, D. Psimaras, M. Resche-Rigon, P. Pradat > Radiation related lymphopenia as a predictor of locoregional recurrence in early breast cancer O. Cho (Korea Republic of), Y. Oh, M. Chun, O.K. Noh, J. Heo > ESTRO guidelines for volume delineation for RT after immediate implant-based reconstruction O. Kaidar-Person (Israel), P. Poortmans, B.V. Offersen > Mastectomy or breast-conserving therapy for early breast cancer: outcome comparison of 7565 cases S. Corradini (Germany), M. Pazos, D. Reitz, S. Schönecker, M. Niyazi, U. Ganswindt, F. Alongi, M. Braun, N. Harbeck, C. Belka > Is proton therapy a “pro” for breast cancer? A comparison of proton vs. non-proton RT using the NCDB M. Chowdhary (USA), A. Lee, S. Gao, P. Barry, R. Diaz, N. Bagadiya, H. Park, J. Yu, L. Wilson, M. Moran, S. Higgins, C. Knowlton, K. Patel > Patient selection for proton therapy of early breast cancer – the DBCG phase II study strategy L.B. Stick (Denmark), E.L. Lorenzen, E.S. Yates, C. Anandadas, K. Andersen, C. Aristei, O. Byrne, S. Hol, I. Jensen, A. Kirby, Y.M. Kirova, L. Marrazzo, A. Matías-Pérez, M.M.B. Nielsen, H.D. Nissen, S. Oliveros, K. Verhoeven, J. Vikström, B.V. Offersen > IMRT versus VMAT for elderly patients with breast cancer: comparison of acute and late toxicities F. Alongi, F. Gregucci (Italy), A. Fiorentino, R. Mazzola, V. Figlia, F. Ricchetti, G. Sicignano, N. Giaj-Levra, S. Naccarato, A. Massocco, S. Corradini, R. Ruggieri > The Radiosensitivity Index (RSI) predicts for outcomes in triple negative breast cancer C. Liveringhouse (USA), N.B. Figura, K.A. Ahmed, G.D. Grass, P. Blumencranz, K. Allen, C. Laronga, M.C. Lee, L.B. Harrison, T.J. Robinson, J.F. Torres-Roca, R. Diaz > Merkel cell polyoma viral load predicts overall survival in patients with Merkel cell carcinoma J. Mueller-von der Gruen (Germany), R. Winkelmann, M. Meissner, U. Wieland, S. Silling, D. Martin, E. Fokas, C. Rödel, F. Rödel, P. Balermpas

PV-0041

PV-0042

PV-0043

PV-0044

PV-0045

PV-0046

PV-0047

PV-0048

PV-0049

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

81